The Weekly Pulse — Edition 27 · March 29, 2026

Published · Researched 2026-09-22

The week in one paragraph

Cystic fibrosis just gained nineteen years. Registry data reported in February puts predicted survival for people with CF at 65 for the 2020–2024 period, up from 46 for 2015–2019 — a leap driven by highly effective CFTR modulator therapies, earlier newborn screening, and better multidisciplinary care. This is not a trial endpoint; it's a population-health outcome, measured the way patients experience it: a disease once routinely fatal in childhood now projects a near-normal lifespan. The CF Foundation's own Threads account is circulating the improving registry numbers, which tells you the institutions feel safe saying it out loud. Nineteen years in a single registry period. That is a generation of research arriving all at once.

Rising

• Medicine adding years and options. Alongside the CF number, Journavx (suzetrigine) won FDA approval on January 30, 2025: the first new class of acute-pain medicine in more than two decades, and a non-opioid — it blocks the NaV1.8 sodium channel instead of touching opioid receptors. It beat placebo in trials; it did not clearly outperform opioids, and it shouldn't be sold as better. Its value is a real alternative to opioid exposure for moderate-to-severe acute pain. Science accounts and a clinician explainer are carrying it on Threads — the right kind of circulation for a drug story. Still watching: the dossier flags its own social-layer observation as incomplete, so the tier can't be finalized on the social side yet.
• Community triumphs, built by hand. Roanoke Rapids, North Carolina, cut the ribbon March 11 on a new skatepark at Emry Park — resident-led, more than $70,000 raised from residents and local businesses, built on converted unused tennis courts, opened with a free community skate jam. And in Milwaukee, the ERAS Seniors Network spent a summer heat advisory handing out about 50 free air conditioners to seniors in the Harambee neighborhood, with free installation from a local training institute. Still watching: whether all 50 units were in place by report date wasn't captured.
• Small and thriving. On September 8, Hillsborough County deputies pulled a tiny kitten off busy I-275 in Florida; by September 10, the sheriff's office reported the kitten — named Dash — adopted and settling into his new home. Still watching: Dash's age and adopter details weren't captured; the outcome was confirmed.

Falling

• The twenty-year drought in new pain medicines — broken by a non-opioid, no less.
• CF as a childhood-fatal disease — the registry now reads like a different illness.
• Empty tennis courts — Roanoke Rapids turned unused public space into exactly what residents asked for.

Quiet signals

• Journavx is approved; where it lands in real prescribing practice is unwritten. Watch adoption, not the announcement.
• Milwaukee's install completion. Whether all 50 units were in place — and whether the story traveled beyond TMJ4's own channels — is still watching.
• Emry Park's exact total beyond "more than $70,000" and opening-day attendance weren't captured. The building is the verified fact; the headcount is still watching.

Scoreboard

N/A — editions are being written out of sequence, so there are no prior calls to grade.

One line to close

More years, more neighbors, one very lucky kitten. A good week for the arithmetic of more life.